Ra Medical Securities Litigation

Ra Medical Systems (RMED) IPO Stock Settlement

Updated: December 10, 2022

Claim Form Deadline: July 9, 2022

Estimated Payout: Varies

Proof required: Yes

Method of payment: Cash

What's This Settlement About?

A class action settlement has been reached in order to settle a lawsuit against RA Medical Systems Inc and their publically traded stock, RMED listed on NASDAQ. The lawsuit stems from allegations that RA Medical made material misstatements and/or omitted material facts about RA Medical's operations, including product defects with DABRA catheters, product recall, off-label marketing of DABRA, and improper payments to physicians. Pursuant to the Settlement, Defendants have agreed to pay or cause to be paid $10,000,000 in cash.

How Do I Qualify?

The Settlement Class consists of all persons and entities that purchased or otherwise acquired the common stock of RA Medical:

• pursuant and/or traceable to RA Medical's IPO; and/or
• between September 27, 2018 and November 27, 2019, inclusive.

How Do I File a Claim?

To be eligible for a payment from the proceeds of the Settlement, you must have submitted a claim form online or postmarked no later than July 9, 2022.

The Court held a hearing on June 13, 2022 at 11:30 a.m.

Filing Class Action Settlement Claims

Please note that your claim form will be rejected if you submit a settlement claim for payout with any fraudulent information. By providing this information and your sworn statement of its veracity, you agree to do so under the penalty of perjury. You would also be harming others that actually qualify for the class action settlement. If you are not sure whether or not you qualify for this class action settlement, visit the class action administrator's website below. OpenClassActions.com is only providing information and is not a class action administrator or a law firm.